Misremembering pictured objects: people of all ages demonstrate the boundary extension illusion.
Am J Psychol.
2002 Summer;115(2):151-67. PubMed PMID:
12041005.
A functional MRI study of the influence of practice on component processes of working memory.
Neuroimage.
2004 May;22(1):211-21. doi: 10.1016/j.neuroimage.2004.01.003. PubMed PMID:
15110011.
Aging, recall and recognition: a study on the sensitivity of the University of Southern California Repeatable Episodic Memory Test (USC-REMT).
J Clin Exp Neuropsychol.
2004 May;26(3):428-40. doi: 10.1080/13803390490510130. PubMed PMID:
15512931.
Sequence learning in pianists and nonpianists: an fMRI study of motor expertise.
Cogn Affect Behav Neurosci.
2006 Sep;6(3):246-59. doi: 10.3758/cabn.6.3.246. PubMed PMID:
17243360.
Regional specificity and practice: dynamic changes in object and spatial working memory.
Brain Res.
2007 Nov 14;1180:78-89. doi: 10.1016/j.brainres.2007.08.057. Epub 2007 Sep 5. PubMed PMID:
17916334; PubMed Central PMCID:
PMC2100391.
Relationship of striatal dopamine synthesis capacity to age and cognition.
J Neurosci.
2008 Dec 24;28(52):14320-8. doi: 10.1523/JNEUROSCI.3729-08.2008. PubMed PMID:
19109513; PubMed Central PMCID:
PMC2880923.
Striatal dopamine and working memory.
Cereb Cortex.
2009 Feb;19(2):445-54. doi: 10.1093/cercor/bhn095. Epub 2008 Jun 11. PubMed PMID:
18550595; PubMed Central PMCID:
PMC2733326.
Relationships between biomarkers in aging and dementia.
Neurology.
2009 Oct 13;73(15):1193-9. doi: 10.1212/WNL.0b013e3181bc010c. PubMed PMID:
19822868; PubMed Central PMCID:
PMC2764726.
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.
Alzheimers Dement.
2010 May;6(3):221-9. doi: 10.1016/j.jalz.2010.03.003. PubMed PMID:
20451870; PubMed Central PMCID:
PMC2920531.
Comparing predictors of conversion and decline in mild cognitive impairment.
Neurology.
2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30. PubMed PMID:
20592257; PubMed Central PMCID:
PMC2906178.
Characterizing Alzheimer's disease using a hypometabolic convergence index.
Neuroimage.
2011 May 1;56(1):52-60. doi: 10.1016/j.neuroimage.2011.01.049. Epub 2011 Jan 27. PubMed PMID:
21276856; PubMed Central PMCID:
PMC3066300.
Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults.
Hum Brain Mapp.
2011 Jun;32(6):947-61. doi: 10.1002/hbm.21081. Epub 2010 Jun 24. PubMed PMID:
20578173; PubMed Central PMCID:
PMC3176660.
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.
Neurobiol Aging.
2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5. PubMed PMID:
19660834; PubMed Central PMCID:
PMC2891865.
Dopamine and frontostriatal networks in cognitive aging.
Neurobiol Aging.
2012 Mar;33(3):623.e15-24. doi: 10.1016/j.neurobiolaging.2011.03.002. Epub 2011 Apr 20. PubMed PMID:
21511369; PubMed Central PMCID:
PMC3245323.
Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.
J Nucl Med.
2012 Apr;53(4):592-600. doi: 10.2967/jnumed.111.094946. Epub 2012 Feb 17. PubMed PMID:
22343502; PubMed Central PMCID:
PMC3640308.
Association of lifetime cognitive engagement and low β-amyloid deposition.
Arch Neurol.
2012 May;69(5):623-29. doi: 10.1001/archneurol.2011.2748. PubMed PMID:
22271235; PubMed Central PMCID:
PMC3747737.
Physical Activity and AD-Related Pathology-Reply.
Arch Neurol.
2012 Jul 1;69(7):940-1. doi: 10.1001/archneurol.2012.510. PubMed PMID:
23753644.
Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Ann Neurol.
2012 Oct;72(4):578-86. doi: 10.1002/ana.23650. PubMed PMID:
23109153; PubMed Central PMCID:
PMC3786871.
Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.
J Neurosci.
2012 Dec 12;32(50):18227-33. doi: 10.1523/JNEUROSCI.3266-12.2012. PubMed PMID:
23238736; PubMed Central PMCID:
PMC3537830.
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
J Nucl Med.
2013 Jan;54(1):70-7. doi: 10.2967/jnumed.112.109009. Epub 2012 Nov 19. PubMed PMID:
23166389; PubMed Central PMCID:
PMC3747730.
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
J Neurosci.
2013 Mar 27;33(13):5553-63. doi: 10.1523/JNEUROSCI.4409-12.2013. PubMed PMID:
23536070; PubMed Central PMCID:
PMC3687777.
Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.
JAMA Neurol.
2013 Aug;70(8):1039-45. doi: 10.1001/jamaneurol.2013.1878. PubMed PMID:
23779022; PubMed Central PMCID:
PMC3779687.
Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.
Neuroimage.
2013 Sep;78:474-80. doi: 10.1016/j.neuroimage.2013.04.048. Epub 2013 Apr 23. PubMed PMID:
23624169; PubMed Central PMCID:
PMC3749874.
The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
Alzheimers Dement.
2013 Nov;9(6):687-698.e1. doi: 10.1016/j.jalz.2012.10.012. Epub 2013 Mar 7. PubMed PMID:
23474040; PubMed Central PMCID:
PMC3823816.
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
JAMA Neurol.
2013 Dec;70(12):1512-9. doi: 10.1001/jamaneurol.2013.4013. PubMed PMID:
24166579; PubMed Central PMCID:
PMC4962545.
Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.
Ann Neurol.
2013 Dec;74(6):826-36. doi: 10.1002/ana.23908. PubMed PMID:
23536396; PubMed Central PMCID:
PMC3748164.
Tracking the earliest pathologic changes in Alzheimer disease.
Neurology.
2014 May 6;82(18):1576-7. doi: 10.1212/WNL.0000000000000392. Epub 2014 Apr 4. PubMed PMID:
24706009.
Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.
Eur J Nucl Med Mol Imaging.
2014 Jul;41(7):1398-407. doi: 10.1007/s00259-014-2753-3. Epub 2014 Mar 20. PubMed PMID:
24647577; PubMed Central PMCID:
PMC4055504.
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease.
Ann Clin Transl Neurol.
2014 Aug;1(8):534-43. doi: 10.1002/acn3.81. Epub 2014 Jul 19. PubMed PMID:
25356425; PubMed Central PMCID:
PMC4184556.
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Brain.
2015 Mar;138(Pt 3):772-83. doi: 10.1093/brain/awu367. Epub 2014 Dec 24. PubMed PMID:
25541191; PubMed Central PMCID:
PMC4339769.
Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.
Alzheimer Dis Assoc Disord.
2015 Apr-Jun;29(2):101-9. doi: 10.1097/WAD.0000000000000071. PubMed PMID:
25437302; PubMed Central PMCID:
PMC4437812.
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.
J Nucl Med.
2015 Apr;56(4):560-6. doi: 10.2967/jnumed.114.149732. Epub 2015 Mar 5. PubMed PMID:
25745091.
Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
J Nucl Med.
2015 Apr;56(4):567-74. doi: 10.2967/jnumed.114.148981. Epub 2015 Mar 5. PubMed PMID:
25745095; PubMed Central PMCID:
PMC5313473.
Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.
JAMA Neurol.
2015 May;72(5):571-81. doi: 10.1001/jamaneurol.2014.4829. PubMed PMID:
25822737; PubMed Central PMCID:
PMC5642905.
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
JAMA.
2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669. PubMed PMID:
25988463; PubMed Central PMCID:
PMC4517678.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA.
2015 May 19;313(19):1924-38. doi: 10.1001/jama.2015.4668. PubMed PMID:
25988462; PubMed Central PMCID:
PMC4486209.
The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
Alzheimers Dement.
2015 Jul;11(7):757-71. doi: 10.1016/j.jalz.2015.05.001. Review. PubMed PMID:
26194311; PubMed Central PMCID:
PMC4510459.
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data.
Alzheimers Dement.
2015 Sep;11(9):1050-68. doi: 10.1016/j.jalz.2014.09.004. Epub 2014 Nov 24. Review. PubMed PMID:
25457431.
Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.
JAMA Neurol.
2015 Oct;72(10):1183-90. doi: 10.1001/jamaneurol.2015.1633. PubMed PMID:
26280102.
Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Brain.
2015 Dec;138(Pt 12):3734-46. doi: 10.1093/brain/awv278. Epub 2015 Sep 29. PubMed PMID:
26419799; PubMed Central PMCID:
PMC4806718.
Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.
Neurology.
2016 Apr 12;86(15):1368-1376. doi: 10.1212/WNL.0000000000002570. Epub 2016 Mar 16. PubMed PMID:
26984945; PubMed Central PMCID:
PMC4831033.
Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
Neurology.
2016 Apr 12;86(15):1377-1385. doi: 10.1212/WNL.0000000000002576. Epub 2016 Mar 11. PubMed PMID:
26968515; PubMed Central PMCID:
PMC4831042.
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study.
Neurobiol Aging.
2016 Dec;48:122-134. doi: 10.1016/j.neurobiolaging.2016.08.021. Epub 2016 Aug 31. PubMed PMID:
27668356.
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
J Alzheimers Dis.
2017;57(2):447-459. doi: 10.3233/JAD-161223. PubMed PMID:
28269787; PubMed Central PMCID:
PMC5366247.
Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline.
Elife.
2017 Feb 8;6. doi: 10.7554/eLife.22978. PubMed PMID:
28177283; PubMed Central PMCID:
PMC5325620.
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Brain.
2017 May 1;140(5):1499-1512. doi: 10.1093/brain/awx046. PubMed PMID:
28334939.
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease.
Front Neurosci.
2017;11:281. doi: 10.3389/fnins.2017.00281. eCollection 2017. PubMed PMID:
28567001; PubMed Central PMCID:
PMC5434146.
Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary Report.
Alzheimers Dement (N Y).
2017 Jun;3(2):177-188. doi: 10.1016/j.trci.2017.02.005. PubMed PMID:
28758146; PubMed Central PMCID:
PMC5526098.
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
JAMA Neurol.
2017 Jun 1;74(6):650-659. doi: 10.1001/jamaneurol.2016.5349. PubMed PMID:
28319241; PubMed Central PMCID:
PMC5822210.
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Neuroimage.
2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3. PubMed PMID:
28587897; PubMed Central PMCID:
PMC5814575.
What would you like to do?